These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9674583)

  • 21. Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation.
    Borowsky B; Kuhn CM
    J Pharmacol Exp Ther; 1991 Jan; 256(1):204-10. PubMed ID: 1671094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional interaction between 5-HT(6) receptors and hypothalamic-pituitary-adrenal axis: cognitive implications.
    Marcos B; Aisa B; Ramírez MJ
    Neuropharmacology; 2008 Mar; 54(4):708-14. PubMed ID: 18206183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
    McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
    Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain.
    Owens MJ; Edwards E; Nemeroff CB
    Eur J Pharmacol; 1990 Nov; 190(1-2):113-22. PubMed ID: 1963847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticosterone implants in the paraventricular nucleus inhibit ACTH and corticosterone responses and the release of corticotropin-releasing factor following neural stimuli.
    Feldman S; Saphier D; Weidenfeld J
    Brain Res; 1992 Apr; 578(1-2):251-5. PubMed ID: 1324761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
    Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
    Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis.
    Beishuizen A; Thijs LG
    J Endotoxin Res; 2003; 9(1):3-24. PubMed ID: 12691614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin 1 stimulation of the hypothalamic-pituitary-adrenal axis.
    Gwosdow AR; Kumar MS; Bode HH
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E65-70. PubMed ID: 2154118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amygdala kindling rate is altered in rats with a deficit in the responsiveness of the hypothalamo-pituitary-adrenal axis.
    Weiss GK; Castillo N; Fernandez M
    Neurosci Lett; 1993 Jul; 157(1):91-4. PubMed ID: 8233039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
    Kent P; Anisman H; Merali Z
    Neuroendocrinology; 2001 Mar; 73(3):203-14. PubMed ID: 11307039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
    Gil-Lozano M; Romaní-Pérez M; Outeiriño-Iglesias V; Vigo E; González-Matías LC; Brubaker PL; Mallo F
    Endocrinology; 2014 Jul; 155(7):2511-23. PubMed ID: 24731096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the adrenocortical axis by surgical stress: involvement of central norepinephrine and interleukin-1.
    DeKeyser FG; Leker RR; Weidenfeld J
    Neuroimmunomodulation; 2000; 7(4):182-8. PubMed ID: 10810250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The central amygdala modulates hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1beta administration.
    Xu Y; Day TA; Buller KM
    Neuroscience; 1999; 94(1):175-83. PubMed ID: 10613507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Hypothalamic-Pituitary-Adrenal Axis and Serotonin Metabolism in Individual Brain Nuclei of Mice with Genetic Disruption of the NK1 Receptor Exposed to Acute Stress.
    Culman J; Mühlenhoff S; Blume A; Hedderich J; Lützen U; Hunt SP; Rupniak NMJ; Zhao Y
    Cell Mol Neurobiol; 2018 Aug; 38(6):1271-1281. PubMed ID: 29948553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
    Karanth S; Linthorst AC; Stalla GK; Barden N; Holsboer F; Reul JM
    Endocrinology; 1997 Aug; 138(8):3476-85. PubMed ID: 9231802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cyclooxygenase inhibitors on the CRH-induced pituitary-adrenocortical activity during crowding stress.
    Bugajski J; Gadek-Michalska A; Bugajski AJ
    J Physiol Pharmacol; 2003 Mar; 54(1):99-108. PubMed ID: 12674222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamo-pituitary-adrenal axis sensitization after chronic salt loading.
    Amaya F; Tanaka M; Hayashi S; Tanaka Y; Ibata Y
    Neuroendocrinology; 2001 Mar; 73(3):185-93. PubMed ID: 11307037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.